Participate in a trial
The Memory Study
The study drug is a potential new administration method of an already approved drug for Alzheimer’s dementia.
8 nights
11 visits
Currently, the treatment is administered daily as an oral tablet. The study drug would replace this with a monthly injection. Participants will receive a single dose of the study drug via subcutaneous injection in the stomach.
If the study drug is approved, it is hoped that the injected drug is more efficient than the oral tablet and that it can provide more relief to people with Alzheimer’s dementia.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males and females
Age 18-55 years old
BMI 18 - 32kg/m²
Weight females > 50kg, males > 55kg
Medical History No significant medical history
Medication Not taking any medication
Smoking History Non-smokers and casual smokers only (no more than 10 cigarettes per week)